作为医药中间体或相关化合物，用于医药研发或生产过程中的关键合成步骤。
医药
合成路线 1（1. 合成：443955-90-6）
产率：61%
合成条件：With manganese(IV) oxide In dichloromethane for 72 h;
实验步骤：c）2,3-二氢 - [1,4]二恶英[2,3-c]吡啶-7-甲醛; 用二氧化锰处理（2,3-二氢 - [1,4]二氧杂环己烯[2,3-c]吡啶-7-基） - 甲醇（250mg，1.5mmol）的二氯甲烷（5mL）溶液（ 650毫克，7.5毫摩尔）。 3天后，将混合物过滤并蒸发，得到白色固体（150mg，61％）; MS（APCI +）m / z 166（MH +）。
参考文献：
- [1] Patent: WO2006/81264, 2006, A1. Location in patent: Page/Page column 26-27 [2] Patent: WO2006/81289, 2006, A2. Location in patent: Page/Page column 24 [3] Patent: WO2006/81182, 2006, A2. Location in patent: Page/Page column 25 [4] Patent: WO2007/118130, 2007, A2. Location in patent: Page/Page column 33 [5] Patent: WO2004/2490, 2004, A2. Location in patent: Page/Page column 54-55 [6] Patent: WO2004/2992, 2004, A1. Location in patent: Page 89 [7] Patent: WO2006/2047, 2006, A2. Location in patent: Page/Page column 94-95 [8] Patent: WO2006/17326, 2006, A1. Location in patent: Page/Page column 26 [9] Patent: WO2006/20561, 2006, A2. Location in patent: Page/Page column 36 [10] Patent: WO2007/16610, 2007, A2. Location in patent: Page/Page column 37 [11] Tetrahedron Letters, 2010, vol. 51, # 38, p. 5038 - 5040 [12] Patent: WO2003/87098, 2003, A1. Location in patent: Page/Page column 61 [13] Patent: EP2221309, 2010, A1. Location in patent: Page/Page column 19 [14] Patent: WO2006/21448, 2006, A1. Location in patent: Page/Page column 70-71 [15] Patent: US2010/324030, 2010, A1. Location in patent: Page/Page column 13 [16] Patent: WO2014/57415, 2014, A2. Location in patent: Page/Page column 17
